… C-type natriuretic peptide (CNP) is a known target for promoting growth and has been … of
cardiovascular disease (CVD). This study aimed to explore the effect of CNP on CVD risk using …

… the risk of progression of kidney disease including macroalbuminuria, but only SGLT2i
reduced the risk of worsening estimated glomerular filtration rate, end-stage kidney disease, or …

… risk of bowel obstruction, there are no data in the literature on the incidence of intestinal
obstruction related to peptide receptor … peritoneal or mesenteric disease. Management strategies …

… This finding was coupled with a 76% disease control rate (DCR), leading the authors to
conclude that in the setting of progressive disease, the risk of PRRT retreatment is outweighed …

… of the disease during pregnancy could mitigate the increased risk of remote cardiovascular
disease. … they may also lower remote cardiovascular disease risk in affected women and their …

… receptor expression during disease, such as overexpression in many neoplasia, can be
exploited by imaging techniques. Therefore, peptide receptor … receptors on various tumors. …

… peptides can promote proliferation of lung tumor cell lines (3,14). Expression of messenger
RNA (mRNA) for the three bombesin-like peptide receptors … -like peptides and their receptors …

… Many immune system-related genetic loci have been identified as disease risk factors,
and both human imaging studies [[23, 24]] and preclinical models [[25, 26]] have identified …

… low cardiovascular disease risk, show reduced endothelial function at an early age. These
findings suggest that C2238-αANP behaves as a cardiovascular disease risk factor through …

… Peptide receptor radionuclide therapy (PRRT) is one of the treatment … risk of disease
progression or death. It also improves the quality of life of the patient. Unfortunately, important risk …